PROLONGED SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH PREVIOUSLY UNTREATED PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA - EFFECT ON REMISSION DURATION AND SURVIVAL - CANCER AND LEUKEMIA GROUP-B STUDY-8583

OZER H GEORGE SL SCHIFFER CA RAO K RAO PN WURSTERHILL DH ARTHUR DD POWELL B GOTTLIEB A PETERSON BA RAI K TESTA JR LEBEAU M TANTRAVAHI R BLOOMFIELD CD

H. Ozer et al., PROLONGED SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH PREVIOUSLY UNTREATED PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA - EFFECT ON REMISSION DURATION AND SURVIVAL - CANCER AND LEUKEMIA GROUP-B STUDY-8583, Blood, 82(10), 1993, pp. 2975-2984

34

Hematology

Blood → ACNP

00064971

82

10

1993

2975 - 2984

ISI

0006-4971(1993)82:10<2975:PSAORI>2.0.ZU;2-N